Sunday, April 25, 2021

Wickramarachchi Laboratories crowned as ‘Woman Entrepreneur of the Year’

 Ruwini Irosha Wickramarachchi, Partner, Wickramarachchi Laboratories with the awards.

Wickramarachchi Laboratories, a forerunner in Ayurveda healthcare products sector, reaffirmed its excellence, receiving two awards at the 24th Sri Lankan Entrepreneur of the Year awards ceremony organized by the Federation of Chambers of Commerce and Industries in Sri Lanka.

Woman Entrepreneur of the Year, National Winner and Winner of Western Province In Medium Category were the two awards received by Ruwini Irosha Wickramarachchi, Partner, and Wickramarachchi Laboratories.

The event of FCCISL, which has helped many of Sri Lankan entrepreneurs reach global standards in terms of productivity and value creation, was recently held at the BMICH with President Gotabhaya Rajapaksa as the Chief Guest.

The award winning woman entrepreneur Ruwini Irosha Wickramarachchi said,’’ This is not the result of an individual effort but a team work of a very dedicated staff and I am grateful to all the customers for having trust in our products. “

Founded way back in 1972, aimed at building a healthy nation, Wickramarachchi Laboratories has come a long way with success to become a fully-fledged institution with a range of more than 200 Ayurvedic products including Ms. Ruwasampatha Face Cream, Anjanaleepa Face Cream, Suwega Cream for Skin Ailments, Wickramarachchi Diyawediya Suwaya, Kapruka Holy Powder, Pawatta Thalsookiri Peniya, Oral Care Mouthwash, Dasapanguwa Powder, Shakthi, Cinnamon Tea and Moringa Capsules. Located in Embaraluwa, Weliweriya, Wickramarachchi Laboratories is equipped with sophisticated machinery and a highly skilled set of professionals.

In its successful journey the company has gained many awards such as Productivity, Shilpa, Entrepreneur and SMIDEX Award etc. In keeping with international standards the company has been able to obtain GMP, Cosmetic GMP, ISO 14001:2015, ISO 22000:2018 and ISO 9001:2015 certificates.

Author:

0 comments: